Alkem Sees Domestic Recovery And International Growth
As Company Receives 10 ANDA Approvals In Financial Third Quarter
India’s Alkem has announced growing domestically in its financial third quarter, after seeing a low first quarter due to COVID-19. The company has also reported progress in the international market, after receiving 10 ANDA approvals from the US FDA in Q3 FY21.
